nodes	percent_of_prediction	percent_of_DWPC	metapath
Alosetron—CYP2E1—liver cancer	0.74	1	CbGaD
Alosetron—CYP1A2—Sorafenib—liver cancer	0.0301	0.365	CbGbCtD
Alosetron—CYP2C9—Sorafenib—liver cancer	0.0271	0.329	CbGbCtD
Alosetron—CYP3A4—Sorafenib—liver cancer	0.0158	0.191	CbGbCtD
Alosetron—CYP3A4—Doxorubicin—liver cancer	0.00956	0.116	CbGbCtD
Alosetron—Ondansetron—CYP2E1—liver cancer	0.00409	1	CrCbGaD
Alosetron—Tachyarrhythmia—Epirubicin—liver cancer	0.00382	0.0385	CcSEcCtD
Alosetron—Tachyarrhythmia—Doxorubicin—liver cancer	0.00354	0.0357	CcSEcCtD
Alosetron—Cholecystitis—Sorafenib—liver cancer	0.00329	0.0332	CcSEcCtD
Alosetron—Haematoma—Sorafenib—liver cancer	0.00301	0.0303	CcSEcCtD
Alosetron—Folliculitis—Sorafenib—liver cancer	0.00301	0.0303	CcSEcCtD
Alosetron—Proctitis—Epirubicin—liver cancer	0.00286	0.0288	CcSEcCtD
Alosetron—Proctitis—Doxorubicin—liver cancer	0.00265	0.0267	CcSEcCtD
Alosetron—Drug interaction—Sorafenib—liver cancer	0.00204	0.0205	CcSEcCtD
Alosetron—Blood pressure increased—Sorafenib—liver cancer	0.00189	0.019	CcSEcCtD
Alosetron—Eczema—Sorafenib—liver cancer	0.00153	0.0154	CcSEcCtD
Alosetron—Abdominal pain upper—Sorafenib—liver cancer	0.00125	0.0126	CcSEcCtD
Alosetron—Nasopharyngitis—Sorafenib—liver cancer	0.00123	0.0124	CcSEcCtD
Alosetron—Gastritis—Sorafenib—liver cancer	0.00121	0.0122	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Sorafenib—liver cancer	0.00121	0.0122	CcSEcCtD
Alosetron—Abdominal discomfort—Sorafenib—liver cancer	0.00114	0.0115	CcSEcCtD
Alosetron—Folliculitis—Epirubicin—liver cancer	0.00111	0.0112	CcSEcCtD
Alosetron—Nail disorder—Epirubicin—liver cancer	0.00108	0.0109	CcSEcCtD
Alosetron—Jaundice—Sorafenib—liver cancer	0.00103	0.0104	CcSEcCtD
Alosetron—Folliculitis—Doxorubicin—liver cancer	0.00103	0.0104	CcSEcCtD
Alosetron—Burning sensation—Epirubicin—liver cancer	0.001	0.0101	CcSEcCtD
Alosetron—Nail disorder—Doxorubicin—liver cancer	0.000996	0.01	CcSEcCtD
Alosetron—Ileus—Epirubicin—liver cancer	0.000986	0.00994	CcSEcCtD
Alosetron—Laryngitis—Epirubicin—liver cancer	0.000968	0.00976	CcSEcCtD
Alosetron—Haemoglobin—Sorafenib—liver cancer	0.000953	0.00961	CcSEcCtD
Alosetron—Haemorrhage—Sorafenib—liver cancer	0.000949	0.00956	CcSEcCtD
Alosetron—Dermatitis atopic—Epirubicin—liver cancer	0.000943	0.00951	CcSEcCtD
Alosetron—Burning sensation—Doxorubicin—liver cancer	0.00093	0.00937	CcSEcCtD
Alosetron—Ileus—Doxorubicin—liver cancer	0.000913	0.0092	CcSEcCtD
Alosetron—Fungal infection—Epirubicin—liver cancer	0.000904	0.00911	CcSEcCtD
Alosetron—Laryngitis—Doxorubicin—liver cancer	0.000896	0.00903	CcSEcCtD
Alosetron—Dermatitis atopic—Doxorubicin—liver cancer	0.000873	0.0088	CcSEcCtD
Alosetron—Arrhythmia—Sorafenib—liver cancer	0.000847	0.00854	CcSEcCtD
Alosetron—Alopecia—Sorafenib—liver cancer	0.000838	0.00845	CcSEcCtD
Alosetron—Fungal infection—Doxorubicin—liver cancer	0.000836	0.00843	CcSEcCtD
Alosetron—Muscle spasms—Sorafenib—liver cancer	0.000794	0.008	CcSEcCtD
Alosetron—Ulcer—Epirubicin—liver cancer	0.000738	0.00744	CcSEcCtD
Alosetron—Bone pain—Epirubicin—liver cancer	0.000729	0.00735	CcSEcCtD
Alosetron—Cough—Sorafenib—liver cancer	0.000721	0.00726	CcSEcCtD
Alosetron—Hypertension—Sorafenib—liver cancer	0.000713	0.00719	CcSEcCtD
Alosetron—Myalgia—Sorafenib—liver cancer	0.000703	0.00709	CcSEcCtD
Alosetron—Abnormal dreams—Epirubicin—liver cancer	0.00069	0.00696	CcSEcCtD
Alosetron—Dry mouth—Sorafenib—liver cancer	0.000688	0.00693	CcSEcCtD
Alosetron—Ulcer—Doxorubicin—liver cancer	0.000683	0.00688	CcSEcCtD
Alosetron—Cystitis noninfective—Epirubicin—liver cancer	0.000682	0.00687	CcSEcCtD
Alosetron—Bone pain—Doxorubicin—liver cancer	0.000674	0.0068	CcSEcCtD
Alosetron—Cystitis—Epirubicin—liver cancer	0.000674	0.0068	CcSEcCtD
Alosetron—Colitis—Epirubicin—liver cancer	0.00067	0.00676	CcSEcCtD
Alosetron—Infection—Sorafenib—liver cancer	0.00067	0.00675	CcSEcCtD
Alosetron—Skin disorder—Sorafenib—liver cancer	0.000655	0.0066	CcSEcCtD
Alosetron—Abnormal dreams—Doxorubicin—liver cancer	0.000638	0.00644	CcSEcCtD
Alosetron—Bladder pain—Epirubicin—liver cancer	0.000631	0.00636	CcSEcCtD
Alosetron—Cystitis noninfective—Doxorubicin—liver cancer	0.000631	0.00636	CcSEcCtD
Alosetron—Cystitis—Doxorubicin—liver cancer	0.000624	0.00629	CcSEcCtD
Alosetron—Colitis—Doxorubicin—liver cancer	0.00062	0.00625	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000614	0.00619	CcSEcCtD
Alosetron—Bladder pain—Doxorubicin—liver cancer	0.000584	0.00589	CcSEcCtD
Alosetron—Fatigue—Sorafenib—liver cancer	0.000581	0.00586	CcSEcCtD
Alosetron—Constipation—Sorafenib—liver cancer	0.000576	0.00581	CcSEcCtD
Alosetron—Pain—Sorafenib—liver cancer	0.000576	0.00581	CcSEcCtD
Alosetron—Eczema—Epirubicin—liver cancer	0.000564	0.00568	CcSEcCtD
Alosetron—Urticaria—Sorafenib—liver cancer	0.000535	0.0054	CcSEcCtD
Alosetron—Eczema—Doxorubicin—liver cancer	0.000522	0.00526	CcSEcCtD
Alosetron—Hypoglycaemia—Epirubicin—liver cancer	0.000519	0.00523	CcSEcCtD
Alosetron—Hypersensitivity—Sorafenib—liver cancer	0.000497	0.00501	CcSEcCtD
Alosetron—Asthenia—Sorafenib—liver cancer	0.000484	0.00487	CcSEcCtD
Alosetron—Hypoglycaemia—Doxorubicin—liver cancer	0.00048	0.00484	CcSEcCtD
Alosetron—Abdominal pain upper—Epirubicin—liver cancer	0.000463	0.00467	CcSEcCtD
Alosetron—Nasopharyngitis—Epirubicin—liver cancer	0.000453	0.00457	CcSEcCtD
Alosetron—Gastritis—Epirubicin—liver cancer	0.000448	0.00452	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000447	0.00451	CcSEcCtD
Alosetron—Abdominal distension—Epirubicin—liver cancer	0.000441	0.00445	CcSEcCtD
Alosetron—Vomiting—Sorafenib—liver cancer	0.000428	0.00432	CcSEcCtD
Alosetron—Abdominal pain upper—Doxorubicin—liver cancer	0.000428	0.00432	CcSEcCtD
Alosetron—Rash—Sorafenib—liver cancer	0.000425	0.00428	CcSEcCtD
Alosetron—Dermatitis—Sorafenib—liver cancer	0.000425	0.00428	CcSEcCtD
Alosetron—Headache—Sorafenib—liver cancer	0.000422	0.00426	CcSEcCtD
Alosetron—Nasopharyngitis—Doxorubicin—liver cancer	0.000419	0.00423	CcSEcCtD
Alosetron—Gastritis—Doxorubicin—liver cancer	0.000415	0.00418	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000414	0.00417	CcSEcCtD
Alosetron—Abdominal distension—Doxorubicin—liver cancer	0.000408	0.00411	CcSEcCtD
Alosetron—Upper respiratory tract infection—Epirubicin—liver cancer	0.000407	0.0041	CcSEcCtD
Alosetron—Pollakiuria—Epirubicin—liver cancer	0.000405	0.00408	CcSEcCtD
Alosetron—Nausea—Sorafenib—liver cancer	0.0004	0.00404	CcSEcCtD
Alosetron—Hyperglycaemia—Epirubicin—liver cancer	0.000395	0.00398	CcSEcCtD
Alosetron—Jaundice—Epirubicin—liver cancer	0.000381	0.00384	CcSEcCtD
Alosetron—Urinary tract infection—Epirubicin—liver cancer	0.00038	0.00383	CcSEcCtD
Alosetron—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000377	0.0038	CcSEcCtD
Alosetron—Sweating—Epirubicin—liver cancer	0.000374	0.00377	CcSEcCtD
Alosetron—Pollakiuria—Doxorubicin—liver cancer	0.000374	0.00377	CcSEcCtD
Alosetron—Sinusitis—Epirubicin—liver cancer	0.000366	0.00369	CcSEcCtD
Alosetron—Hyperglycaemia—Doxorubicin—liver cancer	0.000366	0.00369	CcSEcCtD
Alosetron—Haemoglobin—Epirubicin—liver cancer	0.000352	0.00355	CcSEcCtD
Alosetron—Jaundice—Doxorubicin—liver cancer	0.000352	0.00355	CcSEcCtD
Alosetron—Urinary tract infection—Doxorubicin—liver cancer	0.000351	0.00354	CcSEcCtD
Alosetron—Hepatitis—Epirubicin—liver cancer	0.000351	0.00353	CcSEcCtD
Alosetron—Haemorrhage—Epirubicin—liver cancer	0.000351	0.00353	CcSEcCtD
Alosetron—Hypoaesthesia—Epirubicin—liver cancer	0.000349	0.00352	CcSEcCtD
Alosetron—Sweating—Doxorubicin—liver cancer	0.000346	0.00349	CcSEcCtD
Alosetron—Sinusitis—Doxorubicin—liver cancer	0.000339	0.00342	CcSEcCtD
Alosetron—Haemoglobin—Doxorubicin—liver cancer	0.000326	0.00329	CcSEcCtD
Alosetron—Haemorrhage—Doxorubicin—liver cancer	0.000324	0.00327	CcSEcCtD
Alosetron—Hepatitis—Doxorubicin—liver cancer	0.000324	0.00327	CcSEcCtD
Alosetron—Hypoaesthesia—Doxorubicin—liver cancer	0.000323	0.00325	CcSEcCtD
Alosetron—Arrhythmia—Epirubicin—liver cancer	0.000313	0.00316	CcSEcCtD
Alosetron—Alopecia—Epirubicin—liver cancer	0.00031	0.00312	CcSEcCtD
Alosetron—Flatulence—Epirubicin—liver cancer	0.000301	0.00303	CcSEcCtD
Alosetron—Muscle spasms—Epirubicin—liver cancer	0.000293	0.00296	CcSEcCtD
Alosetron—Arrhythmia—Doxorubicin—liver cancer	0.00029	0.00292	CcSEcCtD
Alosetron—Alopecia—Doxorubicin—liver cancer	0.000287	0.00289	CcSEcCtD
Alosetron—Ill-defined disorder—Epirubicin—liver cancer	0.000283	0.00285	CcSEcCtD
Alosetron—Flatulence—Doxorubicin—liver cancer	0.000278	0.00281	CcSEcCtD
Alosetron—Malaise—Epirubicin—liver cancer	0.000275	0.00277	CcSEcCtD
Alosetron—Muscle spasms—Doxorubicin—liver cancer	0.000271	0.00274	CcSEcCtD
Alosetron—Cough—Epirubicin—liver cancer	0.000266	0.00268	CcSEcCtD
Alosetron—Hypertension—Epirubicin—liver cancer	0.000263	0.00266	CcSEcCtD
Alosetron—Ill-defined disorder—Doxorubicin—liver cancer	0.000262	0.00264	CcSEcCtD
Alosetron—Myalgia—Epirubicin—liver cancer	0.00026	0.00262	CcSEcCtD
Alosetron—Anxiety—Epirubicin—liver cancer	0.000259	0.00261	CcSEcCtD
Alosetron—Discomfort—Epirubicin—liver cancer	0.000257	0.00259	CcSEcCtD
Alosetron—Malaise—Doxorubicin—liver cancer	0.000255	0.00257	CcSEcCtD
Alosetron—Dry mouth—Epirubicin—liver cancer	0.000254	0.00256	CcSEcCtD
Alosetron—Confusional state—Epirubicin—liver cancer	0.000251	0.00253	CcSEcCtD
Alosetron—Infection—Epirubicin—liver cancer	0.000247	0.00249	CcSEcCtD
Alosetron—Cough—Doxorubicin—liver cancer	0.000246	0.00248	CcSEcCtD
Alosetron—Hypertension—Doxorubicin—liver cancer	0.000244	0.00246	CcSEcCtD
Alosetron—Skin disorder—Epirubicin—liver cancer	0.000242	0.00244	CcSEcCtD
Alosetron—Hyperhidrosis—Epirubicin—liver cancer	0.000241	0.00243	CcSEcCtD
Alosetron—Myalgia—Doxorubicin—liver cancer	0.00024	0.00242	CcSEcCtD
Alosetron—Anxiety—Doxorubicin—liver cancer	0.00024	0.00242	CcSEcCtD
Alosetron—Discomfort—Doxorubicin—liver cancer	0.000238	0.00239	CcSEcCtD
Alosetron—Dry mouth—Doxorubicin—liver cancer	0.000235	0.00237	CcSEcCtD
Alosetron—Confusional state—Doxorubicin—liver cancer	0.000232	0.00234	CcSEcCtD
Alosetron—Infection—Doxorubicin—liver cancer	0.000229	0.00231	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000227	0.00229	CcSEcCtD
Alosetron—Skin disorder—Doxorubicin—liver cancer	0.000224	0.00226	CcSEcCtD
Alosetron—Hyperhidrosis—Doxorubicin—liver cancer	0.000223	0.00225	CcSEcCtD
Alosetron—Fatigue—Epirubicin—liver cancer	0.000215	0.00216	CcSEcCtD
Alosetron—Pain—Epirubicin—liver cancer	0.000213	0.00215	CcSEcCtD
Alosetron—Constipation—Epirubicin—liver cancer	0.000213	0.00215	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00021	0.00212	CcSEcCtD
Alosetron—Feeling abnormal—Epirubicin—liver cancer	0.000205	0.00207	CcSEcCtD
Alosetron—Fatigue—Doxorubicin—liver cancer	0.000199	0.002	CcSEcCtD
Alosetron—Urticaria—Epirubicin—liver cancer	0.000198	0.00199	CcSEcCtD
Alosetron—Constipation—Doxorubicin—liver cancer	0.000197	0.00199	CcSEcCtD
Alosetron—Pain—Doxorubicin—liver cancer	0.000197	0.00199	CcSEcCtD
Alosetron—Feeling abnormal—Doxorubicin—liver cancer	0.00019	0.00191	CcSEcCtD
Alosetron—Hypersensitivity—Epirubicin—liver cancer	0.000183	0.00185	CcSEcCtD
Alosetron—Urticaria—Doxorubicin—liver cancer	0.000183	0.00185	CcSEcCtD
Alosetron—Asthenia—Epirubicin—liver cancer	0.000179	0.0018	CcSEcCtD
Alosetron—Hypersensitivity—Doxorubicin—liver cancer	0.00017	0.00171	CcSEcCtD
Alosetron—Asthenia—Doxorubicin—liver cancer	0.000165	0.00167	CcSEcCtD
Alosetron—Vomiting—Epirubicin—liver cancer	0.000158	0.0016	CcSEcCtD
Alosetron—Rash—Epirubicin—liver cancer	0.000157	0.00158	CcSEcCtD
Alosetron—Dermatitis—Epirubicin—liver cancer	0.000157	0.00158	CcSEcCtD
Alosetron—Headache—Epirubicin—liver cancer	0.000156	0.00157	CcSEcCtD
Alosetron—Nausea—Epirubicin—liver cancer	0.000148	0.00149	CcSEcCtD
Alosetron—Vomiting—Doxorubicin—liver cancer	0.000147	0.00148	CcSEcCtD
Alosetron—Rash—Doxorubicin—liver cancer	0.000145	0.00146	CcSEcCtD
Alosetron—Dermatitis—Doxorubicin—liver cancer	0.000145	0.00146	CcSEcCtD
Alosetron—Headache—Doxorubicin—liver cancer	0.000144	0.00146	CcSEcCtD
Alosetron—Nausea—Doxorubicin—liver cancer	0.000137	0.00138	CcSEcCtD
Alosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000136	0.00182	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—TNF—liver cancer	0.000134	0.0018	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—GSTA4—liver cancer	0.000134	0.0018	CbGpPWpGaD
Alosetron—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000134	0.0018	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—GSTA4—liver cancer	0.000132	0.00178	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—GSTA2—liver cancer	0.000131	0.00175	CbGpPWpGaD
Alosetron—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.00013	0.00174	CbGpPWpGaD
Alosetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000129	0.00173	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000128	0.00172	CbGpPWpGaD
Alosetron—CYP1A2—Phase II conjugation—GGT1—liver cancer	0.000128	0.00171	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—GSTA1—liver cancer	0.000126	0.00169	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—NAT2—liver cancer	0.000125	0.00167	CbGpPWpGaD
Alosetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000125	0.00167	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—GGT1—liver cancer	0.000124	0.00167	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—NAT2—liver cancer	0.000123	0.00165	CbGpPWpGaD
Alosetron—CYP2C9—Metapathway biotransformation—GPX3—liver cancer	0.000122	0.00164	CbGpPWpGaD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000118	0.00158	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—HPGDS—liver cancer	0.000117	0.00157	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000115	0.00154	CbGpPWpGaD
Alosetron—CYP1A2—Phase II conjugation—GSTP1—liver cancer	0.000115	0.00154	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000113	0.00152	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000112	0.0015	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—GSTP1—liver cancer	0.000112	0.0015	CbGpPWpGaD
Alosetron—CYP2E1—Metapathway biotransformation—GSTP1—liver cancer	0.00011	0.00148	CbGpPWpGaD
Alosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00011	0.00147	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—IL6—liver cancer	0.000109	0.00145	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000108	0.00145	CbGpPWpGaD
Alosetron—CYP1A2—Phase II conjugation—GSTM1—liver cancer	0.000105	0.00141	CbGpPWpGaD
Alosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000105	0.0014	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—GPX3—liver cancer	0.000105	0.0014	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000104	0.00139	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—PPARA—liver cancer	0.000103	0.00139	CbGpPWpGaD
Alosetron—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000103	0.00139	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—liver cancer	0.000103	0.00138	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—GSTM1—liver cancer	0.000103	0.00137	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000102	0.00137	CbGpPWpGaD
Alosetron—CYP2E1—Metapathway biotransformation—GSTM1—liver cancer	0.000101	0.00136	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000101	0.00135	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—HPGDS—liver cancer	9.98e-05	0.00134	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—GSTA1—liver cancer	9.74e-05	0.00131	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—CYP1A1—liver cancer	9.72e-05	0.0013	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—NAT2—liver cancer	9.63e-05	0.00129	CbGpPWpGaD
Alosetron—CYP2E1—Metapathway biotransformation—CYP1A1—liver cancer	9.59e-05	0.00129	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—CYP2E1—liver cancer	9.52e-05	0.00128	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	9.5e-05	0.00127	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—liver cancer	9.45e-05	0.00127	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—liver cancer	9.45e-05	0.00127	CbGpPWpGaD
Alosetron—CYP2C9—Metapathway biotransformation—CYP2E1—liver cancer	9.39e-05	0.00126	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—liver cancer	9.25e-05	0.00124	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—EPT1—liver cancer	9.23e-05	0.00124	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	9e-05	0.00121	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—GGT1—liver cancer	8.74e-05	0.00117	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	8.72e-05	0.00117	CbGpPWpGaD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	8.49e-05	0.00114	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—CYP2E1—liver cancer	8.13e-05	0.00109	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	8.08e-05	0.00108	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—CYP2E1—liver cancer	8.02e-05	0.00108	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	7.86e-05	0.00105	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—GSTP1—liver cancer	7.85e-05	0.00105	CbGpPWpGaD
Alosetron—CYP2C9—Metapathway biotransformation—GSTP1—liver cancer	7.74e-05	0.00104	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—HPGDS—liver cancer	7.7e-05	0.00103	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—ALB—liver cancer	7.69e-05	0.00103	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—GGT1—liver cancer	7.47e-05	0.001	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—UGDH—liver cancer	7.27e-05	0.000975	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—MYC—liver cancer	7.23e-05	0.00097	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	7.22e-05	0.000967	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—GSTM1—liver cancer	7.21e-05	0.000967	CbGpPWpGaD
Alosetron—CYP2C9—Metapathway biotransformation—GSTM1—liver cancer	7.11e-05	0.000954	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	6.96e-05	0.000933	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—RAF1—liver cancer	6.95e-05	0.000932	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—CYP1A1—liver cancer	6.84e-05	0.000917	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—EPT1—liver cancer	6.84e-05	0.000916	CbGpPWpGaD
Alosetron—CYP2C9—Metapathway biotransformation—CYP1A1—liver cancer	6.74e-05	0.000904	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	6.74e-05	0.000903	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—TNF—liver cancer	6.74e-05	0.000903	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	6.71e-05	0.000899	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—GSTP1—liver cancer	6.71e-05	0.000899	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	6.68e-05	0.000896	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—GSTP1—liver cancer	6.62e-05	0.000887	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—TAT—liver cancer	6.48e-05	0.000869	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—CYP2E1—liver cancer	6.28e-05	0.000842	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	6.19e-05	0.00083	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—GSTM1—liver cancer	6.16e-05	0.000826	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	6.08e-05	0.000815	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	5.95e-05	0.000797	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—CYP1A1—liver cancer	5.84e-05	0.000783	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—GGT1—liver cancer	5.76e-05	0.000773	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	5.76e-05	0.000773	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	5.73e-05	0.000769	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	5.68e-05	0.000762	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—GSTP1—liver cancer	5.18e-05	0.000694	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	5.13e-05	0.000688	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—UGDH—liver cancer	5.11e-05	0.000686	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	5.11e-05	0.000684	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—EPT1—liver cancer	4.81e-05	0.000645	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—GSTM1—liver cancer	4.76e-05	0.000638	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	4.69e-05	0.000629	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—TAT—liver cancer	4.56e-05	0.000611	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—CYP1A1—liver cancer	4.51e-05	0.000605	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	4.48e-05	0.000601	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	4.45e-05	0.000596	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GLUL—liver cancer	4.4e-05	0.000591	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CPT1B—liver cancer	4.4e-05	0.000591	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	4.38e-05	0.000588	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—UGDH—liver cancer	4.37e-05	0.000586	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NR1H4—liver cancer	4.25e-05	0.000569	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTA3—liver cancer	4.18e-05	0.00056	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—EPT1—liver cancer	4.11e-05	0.000551	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—TAT—liver cancer	3.9e-05	0.000522	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	3.83e-05	0.000514	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTA4—liver cancer	3.82e-05	0.000512	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTA2—liver cancer	3.72e-05	0.000499	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTA1—liver cancer	3.59e-05	0.000481	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NAT2—liver cancer	3.55e-05	0.000476	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ALDOB—liver cancer	3.4e-05	0.000456	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—UGDH—liver cancer	3.37e-05	0.000452	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.36e-05	0.00045	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CRABP1—liver cancer	3.25e-05	0.000435	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—EPT1—liver cancer	3.17e-05	0.000425	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CPT1B—liver cancer	3.1e-05	0.000415	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GLUL—liver cancer	3.1e-05	0.000415	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—TAT—liver cancer	3.01e-05	0.000403	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NR1H4—liver cancer	2.99e-05	0.000401	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTA3—liver cancer	2.94e-05	0.000394	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.87e-05	0.000384	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—HPGDS—liver cancer	2.84e-05	0.000381	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTA4—liver cancer	2.69e-05	0.00036	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CPT1B—liver cancer	2.65e-05	0.000355	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GLUL—liver cancer	2.65e-05	0.000355	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.63e-05	0.000352	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTA2—liver cancer	2.62e-05	0.000351	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NR1H4—liver cancer	2.55e-05	0.000342	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PSMD10—liver cancer	2.53e-05	0.000339	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PSMA4—liver cancer	2.53e-05	0.000339	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTA1—liver cancer	2.53e-05	0.000339	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTA3—liver cancer	2.51e-05	0.000337	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NAT2—liver cancer	2.5e-05	0.000335	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GOT2—liver cancer	2.46e-05	0.00033	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.4e-05	0.000322	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ALDOB—liver cancer	2.39e-05	0.000321	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTA4—liver cancer	2.3e-05	0.000308	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CRABP1—liver cancer	2.28e-05	0.000306	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.24e-05	0.000301	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTA2—liver cancer	2.24e-05	0.0003	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CYCS—liver cancer	2.16e-05	0.00029	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTA1—liver cancer	2.16e-05	0.000289	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NAT2—liver cancer	2.13e-05	0.000286	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GGT1—liver cancer	2.12e-05	0.000285	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GOT1—liver cancer	2.12e-05	0.000285	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.06e-05	0.000276	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.05e-05	0.000275	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ALDOB—liver cancer	2.05e-05	0.000274	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GLUL—liver cancer	2.04e-05	0.000274	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CPT1B—liver cancer	2.04e-05	0.000274	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HPGDS—liver cancer	2e-05	0.000268	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.99e-05	0.000266	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NR1H4—liver cancer	1.97e-05	0.000264	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CRABP1—liver cancer	1.95e-05	0.000262	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTA3—liver cancer	1.94e-05	0.00026	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTP1—liver cancer	1.91e-05	0.000256	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—HMOX1—liver cancer	1.88e-05	0.000252	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.81e-05	0.000242	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.78e-05	0.000239	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PSMD10—liver cancer	1.78e-05	0.000239	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PSMA4—liver cancer	1.78e-05	0.000239	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTA4—liver cancer	1.77e-05	0.000238	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.76e-05	0.000236	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTM1—liver cancer	1.75e-05	0.000235	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GOT2—liver cancer	1.73e-05	0.000232	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTA2—liver cancer	1.73e-05	0.000231	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HPGDS—liver cancer	1.71e-05	0.000229	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.7e-05	0.000227	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTA1—liver cancer	1.67e-05	0.000223	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CYP1A1—liver cancer	1.66e-05	0.000223	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NAT2—liver cancer	1.65e-05	0.000221	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP2E1—liver cancer	1.63e-05	0.000218	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ALDOB—liver cancer	1.58e-05	0.000212	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.58e-05	0.000211	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—MTHFR—liver cancer	1.55e-05	0.000208	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.55e-05	0.000207	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.53e-05	0.000204	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYCS—liver cancer	1.52e-05	0.000204	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PSMA4—liver cancer	1.52e-05	0.000204	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PSMD10—liver cancer	1.52e-05	0.000204	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PPARA—liver cancer	1.52e-05	0.000204	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CRABP1—liver cancer	1.51e-05	0.000202	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GOT1—liver cancer	1.49e-05	0.0002	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GGT1—liver cancer	1.49e-05	0.0002	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GOT2—liver cancer	1.48e-05	0.000198	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP2E1—liver cancer	1.39e-05	0.000186	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.35e-05	0.000181	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTP1—liver cancer	1.34e-05	0.00018	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HMOX1—liver cancer	1.32e-05	0.000177	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HPGDS—liver cancer	1.32e-05	0.000177	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CG—liver cancer	1.3e-05	0.000175	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYCS—liver cancer	1.3e-05	0.000174	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GOT1—liver cancer	1.28e-05	0.000171	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GGT1—liver cancer	1.28e-05	0.000171	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PPARG—liver cancer	1.26e-05	0.000168	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTM1—liver cancer	1.23e-05	0.000165	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PSMD10—liver cancer	1.17e-05	0.000157	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PSMA4—liver cancer	1.17e-05	0.000157	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP1A1—liver cancer	1.17e-05	0.000157	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTP1—liver cancer	1.15e-05	0.000154	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CD—liver cancer	1.14e-05	0.000153	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GOT2—liver cancer	1.14e-05	0.000153	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HMOX1—liver cancer	1.13e-05	0.000152	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ALB—liver cancer	1.13e-05	0.000151	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—MTHFR—liver cancer	1.09e-05	0.000146	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP2E1—liver cancer	1.07e-05	0.000144	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PPARA—liver cancer	1.07e-05	0.000143	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTM1—liver cancer	1.05e-05	0.000141	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYCS—liver cancer	1e-05	0.000135	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP1A1—liver cancer	9.99e-06	0.000134	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CB—liver cancer	9.98e-06	0.000134	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GOT1—liver cancer	9.86e-06	0.000132	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GGT1—liver cancer	9.86e-06	0.000132	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.61e-06	0.000129	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—MTHFR—liver cancer	9.32e-06	0.000125	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CG—liver cancer	9.16e-06	0.000123	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PPARA—liver cancer	9.14e-06	0.000123	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTP1—liver cancer	8.85e-06	0.000119	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PPARG—liver cancer	8.84e-06	0.000119	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HMOX1—liver cancer	8.73e-06	0.000117	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.21e-06	0.00011	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTM1—liver cancer	8.14e-06	0.000109	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CD—liver cancer	8.05e-06	0.000108	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ALB—liver cancer	7.95e-06	0.000107	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CG—liver cancer	7.83e-06	0.000105	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP1A1—liver cancer	7.71e-06	0.000103	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PPARG—liver cancer	7.55e-06	0.000101	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—MTHFR—liver cancer	7.19e-06	9.64e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PPARA—liver cancer	7.05e-06	9.46e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CB—liver cancer	7.02e-06	9.41e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CD—liver cancer	6.88e-06	9.23e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ALB—liver cancer	6.79e-06	9.11e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CA—liver cancer	6.08e-06	8.15e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CG—liver cancer	6.04e-06	8.1e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CB—liver cancer	6e-06	8.04e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PPARG—liver cancer	5.83e-06	7.82e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CD—liver cancer	5.31e-06	7.12e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ALB—liver cancer	5.24e-06	7.03e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—AKT1—liver cancer	4.97e-06	6.66e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CB—liver cancer	4.63e-06	6.21e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CA—liver cancer	4.28e-06	5.74e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CA—liver cancer	3.66e-06	4.9e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—AKT1—liver cancer	3.5e-06	4.69e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—AKT1—liver cancer	2.99e-06	4e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CA—liver cancer	2.82e-06	3.78e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—AKT1—liver cancer	2.31e-06	3.09e-05	CbGpPWpGaD
